Protagenic Therapeutics, Inc.
NASDAQ: PTIX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Garo H. Armen
- Employees
- 1
- Headquarters
- New York City, United States
- IPO year
- 2021
- Market cap
- $651.5K
- Website
- https://www.protagenic.com
Loading PTIX…
Loading profile data…Frequently asked questions about PTIX
What does Protagenic Therapeutics, Inc. (PTIX) do?
Protagenic Therapeutics, Inc. operates as a biopharmaceutical firm dedicated to the research and development of novel treatments designed to address neuropsychiatric and mood conditions exacerbated by stress. Foremost among its investigational products is PT00114, a laboratory-synthesized version of the teneurin carboxy-terminal associated pepti...
Where does PTIX trade?
Protagenic Therapeutics, Inc. (PTIX) trades on the NASDAQ Capital Market.
What sector is PTIX in?
Protagenic Therapeutics, Inc. (PTIX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of Protagenic Therapeutics, Inc.?
Garo H. Armen is the chief executive officer of Protagenic Therapeutics, Inc. (PTIX).
Where is Protagenic Therapeutics, Inc. headquartered?
Protagenic Therapeutics, Inc. is headquartered in United States.
Does PTIX pay a dividend?
Protagenic Therapeutics, Inc. (PTIX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did PTIX go public?
Protagenic Therapeutics, Inc. (PTIX) completed its initial public offering in 2021.